Literature DB >> 14759436

Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery.

Sheila C Gardner1, Gary K Grunwald, John S Rumsfeld, Joseph C Cleveland, Lynn M Schooley, Dexiang Gao, Frederick L Grover, Gerald O McDonald, A Laurie Shroyer.   

Abstract

BACKGROUND: Risk factors for 30-day operative (short-term) mortality following coronary artery bypass graft (CABG only) procedures are well established. However, little is known about how the risk factors for short-term mortality following valve replacement procedures (with or without a CABG procedure performed) compare with CABG only risk factors.
METHODS: Department of Veterans Affairs (VA) records (65,585 records) were collected from October 1991 through March 2001 and analyzed. Risk factors for short-term mortality were compared across three subgroups of patients: CABG only surgery (n = 56,318), aortic valve replacement (AVR) with or without CABG (n = 7450), and mitral valve replacement (MVR) with or without CABG (n = 1817). Multivariable logistic regression analyses were used to compare the relative magnitude of risk for 19 candidate predictor variables across subgroups.
RESULTS: Only three patient baseline characteristics differed significantly in magnitude of risk between the procedure groups. Partially or totally dependent functional status significantly increased the risk of short-term mortality for AVR patients (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.29-2.09) and MVR patients (OR 2.21, 95% CI 1.48-3.30), but not for CABG only patients (OR 1.04, 95% CI 0.93-1.16). Conversely, previous heart surgery and New York Heart Association functional class III or IV symptoms conferred greater magnitude of risk for CABG only patients compared with the valve subgroups.
CONCLUSIONS: Overall, the risk factors for short-term mortality following valve replacement and CABG surgery appear to be relatively consistent. However, clinicians should be aware of the importance of preoperative functional status as a unique predictor of mortality following valve surgery.

Entities:  

Mesh:

Year:  2004        PMID: 14759436     DOI: 10.1016/S0003-4975(03)01585-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Relation of QRS shortening to cardiac output during temporary resynchronization therapy after cardiac surgery.

Authors:  Matthew E Spotnitz; Marc E Richmond; Thomas Alexander Quinn; Santos E Cabreriza; Daniel Y Wang; Catherine M Albright; Alan D Weinberg; José M Dizon; Henry M Spotnitz
Journal:  ASAIO J       Date:  2010 Sep-Oct       Impact factor: 2.872

2.  Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis.

Authors:  Jocelyn M Beach; Tomislav Mihaljevic; Lars G Svensson; Jeevanantham Rajeswaran; Thomas Marwick; Brian Griffin; Douglas R Johnston; Joseph F Sabik; Eugene H Blackstone
Journal:  J Am Coll Cardiol       Date:  2013-02-26       Impact factor: 24.094

3.  Statin therapy improves outcomes after valvular heart surgery.

Authors:  Lynn M Fedoruk; Hongkun Wang; Mark R Conaway; Irving L Kron; Karen C Johnston
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

4.  Operative treatment of combined aortic stenosis and coronary artery disease.

Authors:  Nedzad Kadric; Emir Kabil; Emir Mujanovic; Mehdin Hadziselimovic; Mirza Jahic; Stojan Rajkovic; Enes Osmanovic; Sevleta Avdic; Suad Keranovic; Adnan Behrem
Journal:  Med Arch       Date:  2015-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.